JP2002515019A5 - - Google Patents

Download PDF

Info

Publication number
JP2002515019A5
JP2002515019A5 JP1997502307A JP50230797A JP2002515019A5 JP 2002515019 A5 JP2002515019 A5 JP 2002515019A5 JP 1997502307 A JP1997502307 A JP 1997502307A JP 50230797 A JP50230797 A JP 50230797A JP 2002515019 A5 JP2002515019 A5 JP 2002515019A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997502307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002515019A (ja
JP4104164B2 (ja
Filing date
Publication date
Priority claimed from US08/483,059 external-priority patent/US5840740A/en
Priority claimed from US08/476,855 external-priority patent/US5874597A/en
Priority claimed from US08/479,457 external-priority patent/US5763430A/en
Priority claimed from US08/483,057 external-priority patent/US5795885A/en
Priority claimed from US08/487,443 external-priority patent/US5847172A/en
Priority claimed from US08/475,572 external-priority patent/US5840936A/en
Priority claimed from US08/479,455 external-priority patent/US5994336A/en
Application filed filed Critical
Priority claimed from PCT/US1996/010508 external-priority patent/WO1996040728A2/en
Publication of JP2002515019A publication Critical patent/JP2002515019A/ja
Publication of JP2002515019A5 publication Critical patent/JP2002515019A5/ja
Application granted granted Critical
Publication of JP4104164B2 publication Critical patent/JP4104164B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50230797A 1995-06-07 1996-06-07 ナトリウム/プロトン交換体(nhe)の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のnhe阻害効果を評価する方法 Expired - Lifetime JP4104164B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US08/487,443 1995-06-07
US08/483,057 1995-06-07
US08/479,455 1995-06-07
US08/475,572 US5840936A (en) 1995-06-07 1995-06-07 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US08/483,059 1995-06-07
US08/487,443 US5847172A (en) 1995-06-07 1995-06-07 Certain aminosterol compounds and pharmaceutical compositions including these compounds
US08/476,855 1995-06-07
US08/479,457 1995-06-07
US08/475,572 1995-06-07
US08/476,855 US5874597A (en) 1995-06-07 1995-06-07 Certain aminosterol compounds and pharmaceutical compositions including these compounds
US08/483,057 US5795885A (en) 1995-06-07 1995-06-07 Method of inhibiting profileration of cells by administering an aminosterol compound
US08/483,059 US5840740A (en) 1995-06-07 1995-06-07 Aminosterol compounds and a method of treating infection using the aminosterol compounds
US08/479,455 US5994336A (en) 1995-06-07 1995-06-07 Method of inhibiting proliferation of cells by administering an aminosterol compound
US08/479,457 US5763430A (en) 1995-06-07 1995-06-07 Method of treating a viral infection by administering a steroid compound
PCT/US1996/010508 WO1996040728A2 (en) 1995-06-07 1996-06-07 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007223309A Division JP2007314577A (ja) 1995-06-07 2007-08-29 ナトリウム/プロトン交換体(nhe)の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のnhe阻害効果を評価する方法

Publications (3)

Publication Number Publication Date
JP2002515019A JP2002515019A (ja) 2002-05-21
JP2002515019A5 true JP2002515019A5 (https=) 2004-07-29
JP4104164B2 JP4104164B2 (ja) 2008-06-18

Family

ID=27569803

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50230797A Expired - Lifetime JP4104164B2 (ja) 1995-06-07 1996-06-07 ナトリウム/プロトン交換体(nhe)の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のnhe阻害効果を評価する方法
JP2007223309A Withdrawn JP2007314577A (ja) 1995-06-07 2007-08-29 ナトリウム/プロトン交換体(nhe)の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のnhe阻害効果を評価する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007223309A Withdrawn JP2007314577A (ja) 1995-06-07 2007-08-29 ナトリウム/プロトン交換体(nhe)の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のnhe阻害効果を評価する方法

Country Status (10)

Country Link
EP (2) EP0832094B1 (https=)
JP (2) JP4104164B2 (https=)
AT (1) ATE259375T1 (https=)
AU (1) AU723663C (https=)
CA (1) CA2223910C (https=)
DE (1) DE69631527T2 (https=)
DK (1) DK0832094T3 (https=)
ES (1) ES2216049T3 (https=)
PT (1) PT832094E (https=)
WO (1) WO1996040728A2 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
ES2201296T3 (es) * 1996-04-26 2004-03-16 Genaera Corporation Escualmina en combinacion con otros farmacos anticancerigenos para el tratamiento de tumores.
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
EP0923377A1 (en) * 1996-05-17 1999-06-23 Magainin Pharmaceuticals Inc. Therapeutic uses for an aminosterol compound
US7410959B1 (en) * 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
AU5194998A (en) * 1996-11-01 1998-05-29 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and uses therefor
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
PT1274718E (pt) 2000-04-12 2007-01-31 Genaera Corp Processo para a preparação de esteróis 7. alfa-hidroxi 3- aminosubstítuidos utilizando intermediários com um grupo 7. alfa-hidroxilo desprotegido
WO2006119211A2 (en) * 2005-05-02 2006-11-09 Genaera Corporation Methods and compositions for treating ocular disorders
US20080058300A1 (en) * 2006-04-21 2008-03-06 Mclane Michael Induction of weight loss and the selective inhibition of PTP1B
JP2010538072A (ja) * 2007-09-06 2010-12-09 ジェナエラ コーポレイション 糖尿病を治療する方法
AU2009243749B2 (en) * 2008-05-09 2013-11-21 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
BR112014003704A2 (pt) * 2011-09-19 2017-03-07 Eth Zuerich moduladores ror gama
ES2736310T3 (es) * 2012-04-20 2019-12-27 Ohr Pharmaceutical Inc Aminoesteroides para el tratamiento de una enfermedad asociada a PTP1B
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
EP2781217A1 (en) * 2013-03-18 2014-09-24 ETH Zurich ROR gamma modulators
US10040817B2 (en) * 2013-10-03 2018-08-07 Enterin Laboratories, Inc. Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
FR3033563B1 (fr) * 2015-03-12 2018-04-13 Virbac Composes analogues de la squalamine utiles comme agents antibacteriens
FR3055801B1 (fr) * 2016-09-15 2020-10-30 Virbac Derives esters de squalamine pour le traitement des infections
MA50094A (fr) * 2017-09-08 2020-07-15 Enterin Inc Méthodes de traitement des troubles du sommeil, des perturbations du sommeil et de symptômes associés à l'aide de compositions d'aminostérol
EP3829587A4 (en) * 2018-08-03 2022-07-20 Enterin, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN AND GUESS DISORDERS
US11464789B2 (en) 2018-08-03 2022-10-11 Enterin, Inc. Aminosterol compositions and methods of using the same for treating schizophrenia
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
WO2021025974A1 (en) * 2019-08-02 2021-02-11 Enterin, Inc. Human squalamine derivatives, related compositions comprising the same, and methods of using the same
EP4007764B1 (en) 2019-08-02 2026-01-21 Enterin, Inc. Human aminosterol ent-03 compounds, related compositions comprising the same, and methods of using the same
CN112782300B (zh) * 2020-12-25 2022-04-12 山东省食品药品检验研究院 一种胆烷酸的同分异构体及其检测方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192756A (en) * 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
WO1994019366A1 (en) * 1993-02-26 1994-09-01 Magainin Pharmaceuticals Inc. Chemical synthesis of squalamine
DE69412596T2 (de) * 1993-03-10 1999-03-04 Magainin Pharmaceuticals Inc., Plymouth Meeting, Pa. Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel

Similar Documents

Publication Publication Date Title
JP2000500228A5 (https=)
JP2000500033A5 (https=)
JP2000500445A5 (https=)
JP2000500440A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000500361A5 (https=)
JP2000500115A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500112A5 (https=)
JP2000500226A5 (https=)
JP2000500611A5 (https=)
JP2000500051A5 (https=)
JP2000500407A5 (https=)
JP2000500166A5 (https=)
JP2000500397A5 (https=)
JP2000500019A5 (https=)
JP2000500125A5 (https=)
JP2000500044A5 (https=)
JP2000500346A5 (https=)